Germ-Line MutationHispanic or LatinoProstatic Neoplasms
Dr. Aaron Bertolo, MD
NPI1164091179
- Part D claims, 2024
- 388
- Publications
- 3
- Hospital affiliations
- 1
- Industry payments
- $33
- State license
- 1
- Practice address
- 12902 Magnolia Dr, Tampa, FL 33612
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Bertolo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Aaron Bertolo is a hematologist and oncologist in Tampa, Florida
Dr. Bertolo practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
Dr. Bertolo's NPI, 1164091179, was assigned on June 23, 2021. Dr. Bertolo holds Florida license TRN39152.
NPI and contact details
- NPI
- 1164091179NPI Registry (opens in a new tab)
- NPI enumeration date
- June 23, 2021
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Aaron Bertolo practices at Moffitt Cancer Hospital in Tampa, Florida
Dr. Bertolo's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.
- Moffitt Cancer Hospital12902 Magnolia Dr, Tampa, FL 33612
Source: Dmand AI Affiliation Data
Dr. Aaron Bertolo is affiliated with 1 site of care
Dr. Bertolo's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Aaron Bertolo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bertolo practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Moffitt Cancer Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Bertolo practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Moffitt Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Aaron Bertolo is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Bertolo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bertolo is licensed in Florida.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
Hematologists and oncologists near Dr. Bertolo
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
693hematologists and oncologists in Florida84hematologists and oncologists in Tampa59hematologists and oncologists at Moffitt Cancer Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Aaron Bertolo's patients have a median age of 53
Across all payers, Dmand AI patient panel data puts Dr. Bertolo's median patient age at 53, with 61% women.
Dr. Bertolo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 53
Patient panel by sex, all payers
- Women61%
- Men39%
Source: Dmand AI Patient Panel Data
Dr. Aaron Bertolo wrote 388 Medicare Part D claims in 2024
In 2024, Dr. Bertolo wrote 388 Medicare Part D claims for 98 patients. 82% of them were for generic drugs. CMS names the drug for 146 of them, across 7 drugs with 11 or more claims each, at $1,696 in total drug cost. In 2023, CMS named 85 claims across 5 drugs.
Part D claims, 2024388
Drugs named by CMS7
Total drug cost$1,696
Part D patients98
Dr. Bertolo's Part D claims by kind of drug, 2024
- Generic319 claims82%
- Brand-name and other69 claims18%
Dr. Bertolo's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 852024: 14672%
Drugs named by CMS: 7 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Bertolo by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Aaron Bertolo has 3 publications on record
Dmand AI links 3 papers to Dr. Bertolo, published from 2023 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Hispanic or Latino, Prostatic Neoplasms and White. Dr. Bertolo's most frequent co-authors are Akshay Amaraneni, MD, Armaan Dhaliwal and Denis Ruzdija, DO.
Papers3
Years published2023 to 2025
Topics Dr. Bertolo writes about most
- Hispanic or Latino
- Prostatic Neoplasms
- White
Dr. Bertolo's most frequent co-authors
Recent publications by Dr. Bertolo
Caribbean PeopleEthnicityHispanic or Latino
See who Dr. Bertolo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bertolo works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Aaron Bertolo received $33 in industry payments in 2025
CMS Open Payments shows 1 general payment to Dr. Bertolo from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $33.
Companies that paid Dr. Bertolo the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Aaron Bertolo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Aaron Bertolo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Aaron Bertolo's NPI number?
Dr. Aaron Bertolo's NPI number is 1164091179. It was assigned on June 23, 2021, and it is active in the NPI Registry.
What kind of doctor is Dr. Aaron Bertolo?
Dr. Aaron Bertolo is a hematologist and oncologist in Tampa, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Aaron Bertolo practice?
Dr. Bertolo practices at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Bertolo's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.
What is Dr. Aaron Bertolo's medical license number?
Dr. Bertolo holds Florida license TRN39152.
Which hospitals is Dr. Aaron Bertolo affiliated with?
Dr. Bertolo practices at Moffitt Cancer Hospital in Tampa, Florida.
What drugs does Dr. Aaron Bertolo prescribe most?
In 2024 Medicare Part D data, Dr. Bertolo's most prescribed drugs by claims were Atorvastatin Calcium, Amlodipine Besylate and Pantoprazole Sodium.
Has Dr. Aaron Bertolo received payments from drug or device companies?
CMS Open Payments shows $33 in general payments to Dr. Bertolo from 1 company from 2025 to 2025. The largest total came from Sanofi and Genzyme US Companies.
How long has Dr. Aaron Bertolo been practicing?
Dr. Bertolo's NPI was assigned in 2021.
Does Dr. Aaron Bertolo do research?
Dmand AI links 3 publications to Dr. Bertolo, published from 2023 to 2025.
Who does Dr. Aaron Bertolo publish with?
Dr. Bertolo's most frequent co-authors are Akshay Amaraneni, MD (1 shared paper), Armaan Dhaliwal (1 shared paper) and Denis Ruzdija, DO (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card